EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autoantibodies reactive with glomerular endothelial cells and podocytes in patients with membranous nephropathy

Vojtech Petr, Shrey Purohit, Felix Poppelaars, Brandon Renner, Jennifer Laskowski, Russell Whelan, Liudmila Kulik, Jessica Kendrick, Ashley Frazer-Abel, Diana Jalal, Barbara Marcolin, Isabelle Schmelzer und 5 weitere

Journal of Translational Autoimmunity · 2026-06 · 12 · 100342

DOI: 10.1016/j.jtauto.2025.100342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Autoimmunity, 2026-06. Verfasst von Vojtech Petr und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale & objective: Membranous nephropathy (MN) is a glomerular disease caused by autoantibodies reactive with podocyte antigens. The most common antigen is the M-type phospholipase A2 receptor (PLA2R), but autoantibodies to other podocyte antigens have also been identified. Investigators have reported elevated levels of complement fragments in plasma. However, most complement fragments generated on podocytes are likely to pass into the urine and not enter the bloodstream. Further, anti-PLA2R antibodies are usually IgG4 subclass and do not activate the classical pathway of complement. To look for additional autoantibodies capable of generating endovascular complement fragments, we examined whether MN patients have antibodies reactive with endothelial cell antigens. Study design: Retrospective cohort study. Setting & participants: We analyzed plasma samples from 64 patients with MN, and results were compared to healthy controls and patients with chronic kidney disease. Exposure: Plasma and urine complement activation fragments, glomerular endothelial cell and podocyte antibody binding assays, anti-cardiolipin antibody enzyme linked immunosorbent assay. Outcome: Proteinuria, estimated glomerular filtration rate. Analytical approach: Groups were compared with Wilcoxon, Kruskal-Wallis or chi-square tests. Correlations were performed using Pearson's correlation.

Results

Plasma C3a, C4a, C5a, and sC5b-9 levels were elevated in MN patients. Some patients had IgG reacted with glomerular endothelial cells or with podocytes. These antibodies were seen in distinct subsets of patients and did not correlate with the presence of anti-PLA2R antibodies. Higher titers of anti-glomerular endothelial cell antibodies correlated with systemic complement activation, seen by sC5b-9, and disease severity, determined by proteinuria. Anti-cardiolipin IgG levels associated with proteinuria.

Limitations

Assays used immortalized cell lines, and target antigens have not yet been identified.

Conclusions

MN is a disease of autoimmunity directed against podocyte antigens, but some patients may also produce autoantibodies that target antigens on glomerular endothelial cells. The level of these antibodies correlates with adverse clinical findings.

Schlagwörter

Stichwörter der Autor:innen

AutoantibodyComplementGlomerular endothelial cellsMembranous nephropathy

Autor:innen und Institutionen

  • Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Department of Medicine, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, USA.
  • Exsera BioLabs, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, USA.
  • Department of Medicine, Carver College of Medicine, University of Iowa, IA, USA.
  • Iowa City VA HCS, Iowa City, IA, USA.
  • Department of Nephrology and Dialysis, Sorbonne University, Paris, France.

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Petr, V., Purohit, S., Poppelaars, F., Renner, B., Laskowski, J., Whelan, R., Kulik, L., Kendrick, J., Frazer-Abel, A., Jalal, D., Marcolin, B., Schmelzer, I., Debiec, H., Ronco, P., Saleem, M. A., Satchell, S. C., & Thurman, J. M. (2026). Autoantibodies reactive with glomerular endothelial cells and podocytes in patients with membranous nephropathy. Journal of Translational Autoimmunity, 12, 100342. https://doi.org/10.1016/j.jtauto.2025.100342

Vancouver

Petr V, Purohit S, Poppelaars F, Renner B, Laskowski J, Whelan R, et al. Autoantibodies reactive with glomerular endothelial cells and podocytes in patients with membranous nephropathy. Journal of Translational Autoimmunity. 2026;12:100342. doi:10.1016/j.jtauto.2025.100342

BibTeX
@article{Petr2026,
  author = {Petr, Vojtech and Purohit, Shrey and Poppelaars, Felix and Renner, Brandon and Laskowski, Jennifer and Whelan, Russell and Kulik, Liudmila and Kendrick, Jessica and Frazer-Abel, Ashley and Jalal, Diana and Marcolin, Barbara and Schmelzer, Isabelle and Debiec, Hanna and Ronco, Pierre and Saleem, Moin A and Satchell, Simon C and Thurman, Joshua M},
  title = {Autoantibodies reactive with glomerular endothelial cells and podocytes in patients with membranous nephropathy},
  journal = {Journal of Translational Autoimmunity},
  year = {2026},
  volume = {12},
  pages = {100342},
  doi = {10.1016/j.jtauto.2025.100342}
}
Kostenlos starten →